SCHEMBL5351115

SCHEMBL5351115

O=S(=O)(O)c1cc(O)c2c(O)c(/N=N/c3ccccc3)c(S(=O)(=O)O)cc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.71
▸ PRMT1 Q99873 2/20 0.71
▸ CYP2C9 P11712 2/20 0.70
▸ MAPK1 P28482 2/20 0.70
▸ DNASE1L3 Q13609 1/20 0.70
▸ ENPP2 Q13822 7/20 0.60
▸ PHLPP2 Q6ZVD8 1/20 0.58
▸ KMT2A Q03164 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ PRMT3 O60678 1/20 0.50
▸ EP300 Q09472 1/20 0.50
▸ PRMT6 Q96LA8 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ SUMO2 P61956 1/20 0.49
▸ SUMO1 P63165 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP2 Q9HC62 1/20 0.49
▸ APEX1 P27695 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5351119 1.00 CYP1A2 (0.71) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL5859444 0.99 CYP1A2 (0.70) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL11759436 0.99 CYP1A2 (0.70) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL3042237 0.92 PRMT1 (0.74) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL2161281 0.92 PRMT1 (0.74) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL9273197 0.91 PRMT1 (0.73) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL11791675 0.91 PRMT1 (0.73) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL9273205 0.91 PRMT1 (0.73) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL29399950 0.91 PRMT1 (0.73) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3
SCHEMBL24279794 0.89 CYP1A2 (0.70) CYP1A2PRMT1CYP2C9MAPK1DNASE1L3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0477195-A1 SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS THE UPJOHN COMPANY (US) 1992-04-01 — — EP claimed
WO-1990015816-A1 SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS THE UPJOHN COMPANY (US) 1990-12-27 — — WO claimed
US-4714614-A PSEUDOMONAS AND FERRIC ION CHELATING AGENT COLORADO STATE UNIVERSITY (US) 1987-12-22 — — US claimed
US-7306632-B2 Leave-in color conditioner HAIRMARKER LLC (US) 2007-12-11 — — US disclosed
US-20050198746-A1 Leave-in color conditioner HAIRMARKER LLC 2005-09-15 — — US disclosed
WO-1997041844-A1 COMBINATIONS OF ANGIOSTATIC COMPOUNDS ALCON LABORATORIES, INC. (US) 1997-11-13 — — WO disclosed
EP-0477195-A1 SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS THE UPJOHN COMPANY (US) 1992-04-01 — — EP disclosed
WO-1990015816-A1 SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS THE UPJOHN COMPANY (US) 1990-12-27 — — WO disclosed
US-4714614-A PSEUDOMONAS AND FERRIC ION CHELATING AGENT COLORADO STATE UNIVERSITY (US) 1987-12-22 — — US disclosed
Send feedback